View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF Small & MIDCAP MORNING NEWS - 05/17/2024

Growth momentum remains solid, and the publication of Q1 sales bodes well for the future (12.5% organic growth, including 27% for Aerospace). Margins are set to pick up in 2024 (by an estimated 110bp), with the underlying operating profit expected to jump 33%. With good visibility for Aerospace, medium-term potential for Automotive and profitable growth for Medical, we estimate the potential for margin improvement at no less than 500bp in the medium term. We are raising our underlying...

Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF Small & MIDCAP MORNING NEWS - 17/05/2024

La dynamique de croissance reste solide et la publication du CA T1 est de bon augure (croissance organique de 12.5% dont 27% pour l’Aerospace). 2024 devrait voir un redressement des marges (+110 pb estimés) pour un ROC attendu en hausse de 33%. A l’appui d’une bonne visibilité pour l’aéronautique, d’un potentiel MT pour l’automobile et d’une croissance profitable pour le Médical, nous estimons le potentiel d’amélioration des marges à au moins 500 pb à MT. Nous relevons nos estimations...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Walmart 1Q24/25 results. Azelis: Share placement by EQT and PSP. Belgian telcos: Digi mobile prices to be well below competition, targets 10% mkt share. EVS: Slow start, sales guidance held on strong pipeline, EBIT guidance below consensus. Exmar: Stable start to the year. Prosus: Fabricio Bloisi (CEO iFood) appointed as group CEO. Sif Group: 1Q24 pretty much in line, timing shifts a bit

Thijs Berkelder
  • Thijs Berkelder

SIF : Weaker than expected Q1 performance

>Production down 13% y-o-y, adjusted EBITDA down 26% - Production in 24Q1 is down 13% y-o-y to 42kt from 48kt, indicating it is on track for 165kt for FY24, in-line with previous guidance and down 14% from 192kt in 2023. Monopiles and transition pieces were manufactured for Dogger Bank C. In addition, SIF manufactured smaller diameter components for offshore steel structures, mostly gas jackets and substations.Contribution margin is down 1.2% y-o-y to € 33.6m (fr...

Jerôme Bodin ... (+2)
  • Jerôme Bodin
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 05/16/2024

We have tactically downgraded the energy sector from Overweight to Neutral (excl. oil services on which we are maintaining our Overweight rating) and dropped Shell Plc from our Large Caps list. The IEA report has accelerated the downswing for the energy sector, which could continue in the days ahead. June will be a better month to come back to the sector. - ...

Jerôme Bodin ... (+2)
  • Jerôme Bodin
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 16/05/2024

Nous dégradons tactiquement à Neutre le secteur de l’énergie (hors Services Pétroliers sur lesquels nous conservons une opinion Surperformance) et faisons sortir Shell plc de notre liste Large Caps. Le rapport AIE a accéléré la baisse du secteur énergie, qui pourrait se poursuivre dans les jours qui viennent. Juin sera un meilleur mois pour revenir sur le secteur. - ...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf

Dermapharm Holding SE : Strong Q1 reporting supports our Outperform ra...

>Group Q1 figures significantly above expectations - At group level, Dermapharm published a set of strong figures in which the strong organic growth at Branded Pharma and the contributions from the Pandemic Preparedness Programme (PPP) significantly mitigated the loss of sales and earnings from the cooperation with BioNTech. Group sales came in at € 298.7m (-6.4%), which was 6.7% above our estimates and 3.6% above the consensus. Adjusted EBITDA was € 88.7m (-16.2%), 1...

 PRESS RELEASE

EQS-News: Strong organic growth in core markets underscores resilience...

EQS-News: Dermapharm Holding SE / Key word(s): Quarterly / Interim Statement/Quarter Results Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy 15.05.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Strong organic growth in core marketsunderscores resilience of Dermapharm Holding SE's corporate strategy    Robust, double-digit organic growth in high-margin "branded pharmaceuticals" largely offsets projected decline in vaccine production. Revenue in "Other healthcare prod...

 PRESS RELEASE

EQS-News: Dermapharm Holding SE unterstreicht mit einem starken organi...

EQS-News: Dermapharm Holding SE / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis Dermapharm Holding SE unterstreicht mit einem starken organischen Wachstum in den Kernmärkten die Resilienz der Firmenstrategie 15.05.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dermapharm Holding SE unterstreicht mit einem starken organischen Wachstum in den Kernmärkten die Resilienz der Firmenstrategie   Starkes zweistelliges organisches Wachstum bei margenstarken „Markenarzneimitteln“ kompensiert mehrheitlich den geplan...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AB InBev: Busy BEES. Ahold Delhaize: Small beat, comforting confirmation of 2024 guidance. AMG: 1Q24 better than expected, FY guidance intact, strategic projects on schedule. Bekaert: Soft start to the year with 7% sales miss, FY guidance maintained. Euronav: Transformation at full speed. Marel: Another lacklustre quarter. Montea: 2025 guidance raised, valuations moving into positive territory. SBM Offshore: In-line Q1 trading update. Sif Group: Preview - normal quarter e...

Klaus Ringel ... (+2)
  • Klaus Ringel
  • Michael Foundoukidis

NORMA Group SE : Q1 2024 profit margins showing further sequential imp...

>Q1 2024 results look broadly in line with our expectations - Norma’s Q1 2024 reported group sales are down 2% y-o-y to € 309m (in-line with ODDO BHF; -1% vs css) with an organic growth rate of -1%. Group adj. EBIT is +14% y-o-y to € 25.7m (+1% vs ODDO BHF& css) with an adj. EBIT margin of 8.3% in the quarter under review. The sequential improvement of Norma’s adj. EBIT margin (Q1 2023: 7.2%; Q4 2023: Q1 2024: 8.0%) is said to be driven by a more efficient production...

Jerôme Bodin
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 03/05/2024

Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...

Jerôme Bodin
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 05/03/2024

Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aperam: In-line 1Q24 EBITDA, FCF marked by WC build, 2Q24 guidance below consensus. Ayvens: Taking the brakes off. BAM: Not the best start to the year. bpost: 1Q24 in line with consensus but beat vs INGF, no outlook yet. Brunel International: good set of 1Q24 results – 5% beat on EBIT, comforting trends. B&S Group: Preview - should be a non-event. DEME Group: Preview - should be a non-event. D'Ieteren: Febiac April registrations flat YoY, VW brands up 8.4%. GBL: NAV per share in ...

Martijn Den Drijver
  • Martijn Den Drijver

Royal BAM Group : Q1 2024 a soft quarter but investment case stands

>Lowering 2024 estimates, 2025-2026 unchanged, investment case stands - We maintain our Outperform rating and price target after the mixed/disappointing Q1 2024 results. We lower our 2024 adj. EBITDA by 6% (adj. EBITDA margin 4.6% instead of 4.8%) but keep our 2025 and 2026 largely unchanged. Despite the disappointment over the Q1 profitability levels, our investment case stands with slowly but surely improving operational and financial performance as the old lower ma...

Fatma Agnès Hamdani
  • Fatma Agnès Hamdani

Glanbia : Reprise des volumes au T1. La marge d’EBITDA de GPN attendue...

>Recul de 5.4% en organique au T1 moins fort que prévu grâce à une meilleure orientation des volumes - Glanbia a publié hier son interim trading statement sur 3 mois. L’évolution organique du CA T1 ressort meilleure que notre attente à -5.4% (vs -7.5%e). Elle s’appuie sur des volumes en hausse de 1.5% (vs +0.7%e) et un effet prix de -6.9%, principalement lié à l’évolution des cotations des produits laitiers et aux opérations de promotion pour GPN. La progression des ...

Jean Danjou ... (+3)
  • Jean Danjou
  • Oliver Metzger
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 02/05/2024

Nous sortons GALP de notre liste ODDO BHF European Large Caps. La valeur a réalisé une performance de +31,3% depuis son entrée le 20 mars dernier. Notre analyste adopte ce jour une opinion Neutre (vs Surperformance) sur la valeur qui a atteint notre objectif de cours. - ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch